Literature DB >> 6434594

Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.

L A Erickson, M H Ginsberg, D J Loskutoff.   

Abstract

In this study, we demonstrate the presence of a previously undescribed fibrinolytic inhibitor in human serum. It has an apparent molecular weight of 50,000 and is not detected in serum derived from platelet-poor plasma, suggesting that it originates from platelets. This conclusion is supported by a number of observations. For example, extracts of washed, gel-filtered human platelets contain an inhibitor of similar activity and size, and physiological concentrations of thrombin induce its release from the platelets. Moreover, the kinetics and dose dependency of this release are similar to those observed for the release of platelet factor 4, and the release of both molecules is blocked by pretreating the platelets with prostaglandin E1 and theophylline. Mixing experiments, which were devised to investigate the specificity of the inhibitor, showed that the fibrinolytic activity initiated by both urokinase and tissue-type plasminogen activator was blocked by platelet releasate in a dose-dependent manner. In both cases, the amount of inhibition increased when the releasates were preincubated with the purified activators, indicating a direct interaction between the activators and an inhibitor(s). The inhibitory activity was removed by preincubating the releasates with antiserum prepared against an antiactivator purified from cultured bovine aortic endothelial cells. These results indicate that platelets contain an inhibitor which is released by thrombin, inhibits both urokinase and tissue-type plasminogen activator, and is immunologically similar to an inhibitor produced by endothelial cells. This molecule may represent a new class of inhibitors, the antiactivators, which function together with alpha 2-antiplasmin to regulate the fibrinolytic system of the blood. Its release from platelets by thrombin may protect the growing thrombus against premature dissolution initiated by plasminogen activators released by the endothelium.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434594      PMCID: PMC425316          DOI: 10.1172/JCI111559

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Platelets and fibrinolysis.

Authors:  J H Joist
Journal:  Thromb Haemost       Date:  1977-12-15       Impact factor: 5.249

2.  Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.

Authors:  D J Loskutoff; T E Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

3.  Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterization, and relationship to antiheparin in pig platelets.

Authors:  J H Joist; S Niewiarowski; N Nath; J F Mustard
Journal:  J Lab Clin Med       Date:  1976-04

4.  Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma.

Authors:  B Wiman; D Collen
Journal:  Eur J Biochem       Date:  1977-08-15

5.  Platelet antiheparin activity: storage site and release mechanism.

Authors:  P N Walsh; G Gagnatelli
Journal:  Blood       Date:  1974-08       Impact factor: 22.113

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

8.  The isolation and characterisation of a platelet-specific beta-globulin (beta-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets.

Authors:  S Moore; D S Pepper; J D Cash
Journal:  Biochim Biophys Acta       Date:  1975-02-27

9.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses.

Authors:  J C Unkeless; A Tobia; L Ossowski; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

10.  Isolation of rat transferrin using CNBr-activated sepharose 4B.

Authors:  H G Van Eijk; W L Van Noort
Journal:  J Clin Chem Clin Biochem       Date:  1976-10
View more
  47 in total

1.  Achieving Optimal Reperfusion without Adjunctive Antithrombotic Therapy: Novel Thrombolytic Dosing Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Transforming growth factor-ßs as modulators of pericellular proteolytic events.

Authors:  J Keski-Oja; J Lohi; M Laiho
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

Review 3.  Glomerular fibrin deposition and removal.

Authors:  J M Bergstein
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

4.  Identification of a plasminogen activator derived from nasopharyngeal carcinoma.

Authors:  T Kosugi; G W Huang; M Nakamura; S Koja; H T Nong
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

5.  Distribution of plasminogen activator inhibitor (PAI-1) in tissues.

Authors:  A J Simpson; N A Booth; N R Moore; B Bennett
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

6.  cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.

Authors:  D Ginsburg; R Zeheb; A Y Yang; U M Rafferty; P A Andreasen; L Nielsen; K Dano; R V Lebo; T D Gelehrter
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

7.  [Significance of the endothelium of the vascular wall for maintaining hemostasis].

Authors:  U Delvos; G Müller-Berghaus
Journal:  Klin Wochenschr       Date:  1985-12-16

8.  Effect of polymyxin B and colimycin on induction of plasminogen antiactivator by lipopolysaccharide in human endothelial cell culture.

Authors:  F Dubor; A M Dosne; L A Chedid
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

9.  Platelet release protein which inhibits plasminogen activators.

Authors:  N A Booth; J A Anderson; B Bennett
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

10.  Acute ischemic stroke thrombi have an outer shell that impairs fibrinolysis.

Authors:  Lucas Di Meglio; Jean-Philippe Desilles; Véronique Ollivier; Mialitiana Solo Nomenjanahary; Sara Di Meglio; Catherine Deschildre; Stéphane Loyau; Jean-Marc Olivot; Raphaël Blanc; Michel Piotin; Marie-Christine Bouton; Jean-Baptiste Michel; Martine Jandrot-Perrus; Benoît Ho-Tin-Noé; Mikael Mazighi
Journal:  Neurology       Date:  2019-09-20       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.